Baxter International Inc. (BAX)

NYSE: BAX · Real-Time Price · USD

18.47

-0.69 (-3.60%)

At close: Oct 31, 2025, 4:00 PM EDT

18.45

-0.02 (-0.11%)

After-hours: Oct 31, 2025, 7:58 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
United States Revenue	6.08B	5.85B	Log In	Log In	Log In	Upgrade
Emerging Markets Revenue	-	1.35B	Log In	Log In	Log In	Upgrade
Rest of World Revenue	-	3.44B	Log In	Log In	Log In	Upgrade
Revenue (Other)	4.94B	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	11.02B	10.64B	Log In	Log In	Log In	Upgrade

Revenue by Geography 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Americas Revenue	-	-	Log In	Log In	Log In	Upgrade
EMEA Revenue	-	-	Log In	Log In	Log In	Upgrade
APAC Revenue	-	-	Log In	Log In	Log In	Upgrade
Hillrom Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	11.02B	10.64B	Log In	Log In	Log In	Upgrade

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Medication Delivery Revenue	-	-	Log In	Log In	Log In	Upgrade
Clinical Nutrition Revenue	-	-	Log In	Log In	Log In	Upgrade
Infusion Therapies Revenue	4.06B	4.10B	Log In	Log In	Log In	Upgrade
Advanced Surgery Revenue	1.16B	1.10B	Log In	Log In	Log In	Upgrade
Medical Products & Therapies Revenue	5.23B	5.21B	Log In	Log In	Log In	Upgrade
Patient Support Systems Revenue	-	-	Log In	Log In	Log In	Upgrade
Surgical Solutions Revenue	-	-	Log In	Log In	Log In	Upgrade
Care & Connectivity Solutions Revenue	1.88B	1.81B	Log In	Log In	Log In	Upgrade
Front Line Care Revenue	1.15B	1.14B	Log In	Log In	Log In	Upgrade
Healthcare Systems & Technologies Revenue	3.03B	2.95B	Log In	Log In	Log In	Upgrade
Injectables and Anesthesia Revenue	1.38B	1.37B	Log In	Log In	Log In	Upgrade
Drug Compounding Revenue	1.09B	1.04B	Log In	Log In	Log In	Upgrade
Pharmaceuticals Revenue	2.47B	2.41B	Log In	Log In	Log In	Upgrade
Chronic Therapies Revenue	-	-	Log In	Log In	Log In	Upgrade
Acute Therapies Revenue	-	-	Log In	Log In	Log In	Upgrade
Kidney Care Revenue	-	-	Log In	Log In	Log In	Upgrade
Other Revenue (Post-Q2 2023 Reporting)	302.00M	67.00M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-10.72B	-10.57B	Log In	Log In	Log In	Upgrade
Revenue (Total)	11.02B	10.64B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BioPharma Solutions Revenue	-	-	Log In	Log In	Log In	Upgrade
Other Revenue (Pre-Q3 2023 Reporting)	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	11.02B	10.64B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Medical Products & Therapies Operating Income	973.00M	950.00M	Log In	Log In	Log In	Upgrade
Healthcare Systems & Technologies Operating Income	460.00M	468.00M	Log In	Log In	Log In	Upgrade
Pharmaceuticals Operating Income	285.00M	313.00M	Log In	Log In	Log In	Upgrade
Kidney Care Operating Income	-	-	Log In	Log In	Log In	Upgrade
Other Operating Income	23.00M	18.00M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-1.76B	-1.74B	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-14.00M	14.00M	Log In	Log In	Log In	Upgrade

EBIT by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Americas Operating Income	-	-	Log In	Log In	Log In	Upgrade
EMEA Operating Income	-	-	Log In	Log In	Log In	Upgrade
APAC Operating Income	-	-	Log In	Log In	Log In	Upgrade
Hillrom Operating Income	-	-	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-14.00M	14.00M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-14.00M	14.00M	Log In	Log In	Log In	Upgrade

Updated Oct 30, 2025. Data Source: Fiscal.ai.